The Efficacy and Safety of Endoscopic Submucosal Dissection (ESD) Combined With Radiofrequency Ablation (RFA) Sequential Therapy for Extensive Esophageal Lesions
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.17022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Yuan Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Radiofrequency Ablation, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Zhongda Hospital Affiliated to Southeast University, Jiangsu Province High-Level Hospital Construction Funds, Nanjing Science and Technology Development Program.
Abstract (Originalsprache)
Purpose
This study aimed to evaluate the efficacy and safety of a sequential treatment combining endoscopic submucosal dissection (ESD) with radiofrequency ablation (RFA) for extensive esophageal lesions, focusing on reducing esophageal stenosis and improving patients' quality of life.
Methods
We conducted a retrospective analysis of patients with extensive esophageal lesions who underwent sequential treatment of ESD and RFA. Lesion characteristics were assessed using Lugol's iodine staining, white‐light endoscopy, and ultrasound endoscopy. The non‐stained area was treated with ESD, and the remaining lightly stained area was subsequently treated with RFA.
Results
A total of 80 patients were enrolled in the study. The sequential therapy significantly reduced the incidence of esophageal stenosis compared to ESD monotherapy. The postoperative adverse events were lower in the sequential therapy group. There was no significant difference in postoperative recurrence rate between the two groups.
Conclusion
Sequential ESD‐RFA therapy significantly reduces stricture rates (30% vs. 60%, p = 0.02) and improves 12‐month quality of life (SF‐36: 82.55 vs. 74.40, p = 0.001) compared to ESD monotherapy, while maintaining equivalent complete remission rates (100% vs. 96.7%, p = 0.16). This approach is particularly advantageous for lesions > 10 cm or involving > 3/4 circumference.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School of Southeast University, Nanjing, China.
- Department of Gastroenterology, Zhongda Hospital Southeast University, Nanjing, China.
ORCID-Profile: Yuan Ding, Qin Lu, Ruihua Shi
Förderung
- China Postdoctoral Science Foundation
- Zhongda Hospital Affiliated to Southeast University, Jiangsu Province High-Level Hospital Construction Funds
- Nanjing Science and Technology Development Program
Zitieren
APA
Ding, Y., Chen, L., Yin, X., Lu, Q., Wang, Z., Zhu, Y., & Shi, R. (2025). The Efficacy and Safety of Endoscopic Submucosal Dissection (ESD) Combined With Radiofrequency Ablation (RFA) Sequential Therapy for Extensive Esophageal Lesions. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.17022
Vancouver
Ding Y, Chen L, Yin X, Lu Q, Wang Z, Zhu Y, et al. The Efficacy and Safety of Endoscopic Submucosal Dissection (ESD) Combined With Radiofrequency Ablation (RFA) Sequential Therapy for Extensive Esophageal Lesions. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.17022
BibTeX
@article{Ding2025,
author = {Ding, Yuan and Chen, Lu and Yin, Xiaochun and Lu, Qin and Wang, Zhi and Zhu, Yinnan and Shi, Ruihua},
title = {The Efficacy and Safety of Endoscopic Submucosal Dissection (ESD) Combined With Radiofrequency Ablation (RFA) Sequential Therapy for Extensive Esophageal Lesions},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.17022}
}
EUVIMED